Alumis, Inc. (ALMS)
6.78
-0.04
(-0.59%)
USD |
NASDAQ |
Oct 23, 16:00
6.79
+0.01
(+0.15%)
After-Hours: 20:00
Alumis Enterprise Value : 405.40M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 405.40M |
| October 22, 2026 | 410.54M |
| October 21, 2026 | 409.26M |
| October 20, 2026 | 395.12M |
| October 19, 2026 | 348.86M |
| October 16, 2026 | 320.59M |
| October 15, 2026 | 345.00M |
| October 14, 2026 | 312.88M |
| October 13, 2026 | 377.13M |
| October 12, 2026 | 441.38M |
| October 09, 2026 | 454.23M |
| October 08, 2026 | 429.82M |
| October 07, 2026 | 404.12M |
| October 06, 2026 | 424.68M |
| October 05, 2026 | 413.11M |
| October 02, 2026 | 414.40M |
| October 01, 2026 | 460.66M |
| September 30, 2026 | 483.79M |
| September 29, 2026 | 470.94M |
| September 28, 2026 | 454.23M |
| September 25, 2026 | 446.52M |
| September 24, 2026 | 470.94M |
| September 23, 2026 | 490.21M |
| September 22, 2026 | 576.31M |
| September 21, 2026 | 549.33M |
| Date | Value |
|---|---|
| September 18, 2026 | 532.62M |
| September 17, 2026 | 539.05M |
| September 16, 2026 | 554.47M |
| September 15, 2026 | 613.58M |
| September 14, 2026 | 718.95M |
| September 11, 2026 | 713.81M |
| September 10, 2026 | 806.34M |
| September 09, 2026 | 793.49M |
| September 08, 2026 | 893.72M |
| September 04, 2026 | 960.54M |
| September 03, 2026 | 993.96M |
| September 02, 2026 | 864.16M |
| September 01, 2026 | 751.08M |
| August 31, 2026 | 2.337B |
| August 28, 2026 | 2.410B |
| August 27, 2026 | 2.517B |
| August 26, 2026 | 2.569B |
| August 25, 2026 | 2.613B |
| August 24, 2026 | 2.494B |
| August 21, 2026 | 2.640B |
| August 20, 2026 | 2.472B |
| August 19, 2026 | 2.617B |
| August 18, 2026 | 2.731B |
| August 17, 2026 | 2.811B |
| August 14, 2026 | 2.787B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 662.44B |
| Corcept Therapeutics, Inc. | 8.967B |
| Aclaris Therapeutics, Inc. | 434.64M |
| BioAge Labs, Inc. | -82.45M |
| ANI Pharmaceuticals, Inc. | 1.903B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -142.22M |
| Revenue (Quarterly) | 1.662M |
| Total Expenses (Quarterly) | 143.88M |
| EPS Diluted (Quarterly) | -1.114 |
| Gross Profit Margin (Quarterly) | 47.41% |
| Profit Margin (Quarterly) | -8.56K% |
| Earnings Yield | -56.18% |
| Normalized Earnings Yield | -51.64 |